Coferons and methods of making and using them
US-2015105553-A1 · Apr 16, 2015 · US
US11970448B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11970448-B2 |
| Application number | US-202016929528-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 15, 2020 |
| Priority date | Apr 7, 2011 |
| Publication date | Apr 30, 2024 |
| Grant date | Apr 30, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. in vivo) to form a multimer, (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector element that joins the ligand moiety and the linker element. In an aqueous media, such contemplated monomers may join together via each linker element and may thus be capable of modulating one or more biomolecules substantially simultaneously, e.g., modulate two or more binding domains on a protein or on different proteins.
Opening claim text (preview).
What is claimed is: 1. A therapeutic composition comprising a first monomer selected from the group consisting of: and a second monomer selected from the group consisting of: and pharmaceutically acceptable salts, stereoisomers, or hydrates thereof. 2. The therapeutic composition of claim 1 , wherein the first monomer is and the second monomer is 3. A therapeutic composition comprising a first monomer selected from the group consisting of: and a second monomer selected from the group consisting of: and pharmaceutically acceptable salts, stereoisomers, or hydrates thereof.
with hydrocarbon radicals, substituted by nitrogen atoms · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
with only one oxygen atom as ring hetero atom in the oxygen-containing ring · CPC title
Boronic and borinic acid compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.